Antiepileptiklerin D vitamini ve kalsiyum düzeylerine etkisi

Abstract

Purpose: The purpose of our study is to investigate Vitamin D and calcium levels in epilepsy patients using different antiepileptic agents and to investigate the relationship between vitamin D levels and various factors such as the type of antiepileptic agent, patient age and gender.
 Methodology: This retrospective case-control study enrolled a total of 290 participants, including 141 epilepsy patients followed up in AlanyaAlaaddinKeykubat University neurology outpatient clinic and 150 healthy individuals who applied to the neurology outpatient clinic for different reasons from January 2018 to January 2021. Demographics, detailed history, use of medications, duration of antiepileptic use, plasma 25-hydroxy Vitamin D and calcium levels of all participants were recorded.
 Results: The average Vitamin D level was 15.46 in the epilepsy group and 16.95 in the control group. Vitamin D level did not differ significantly by group (p>0.05). No significant relationship was found between age and vitamin D levels in both groups, and Vitamin D levels were statistically significantly lower in women in the epilepsy group. Vitamin D level was below 20 in 69.6% of healthy control group, 78.9% of carbamazepine users, 62.5% of lacosamide users, all lamotrigine users, 66.7% of levatiracetam users, and 72.4% of sodium valproate users. There was no significant relationship between Vitamin D level and the drug used (p>0.05).There was a significant relationship only between calcium level and carbamazepine (p

Evaluation of Osteoporosis Among Epileptic Patients on Monotherapy

“…There are several reasons for the increase in the risk of fractures in epileptic patients, including the risk of a seizure-related fracture and fall, as well as an imbalance between bone formation and bone resorption as a side effect of ASM. Different studies report that the enzyme inducer, the non-enzyme inducer and enzyme inhibitor ASM were associated with an increase in the fracture rate in epileptic patients (4)(5)(6)(7) . These ASM cause abnormalities in calcium metabolism, including hypocalcemia, hypophosphatemia, elevated serum alkaline phosphatase, serum parathyroid hormone, and low vitamin D, which in turn affects bone metabolism (8) .…”